← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $348K of BioMarin Pharmaceutical Inc.

Sold$347,750
$69.55Price
5,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Oct 25. Filed Tue, Oct 29, 7:16 PM ET, after the close. Not investment advice.